Dual-Targeted Drug Delivery to Myeloid Leukemia Cells via Complement- and Transferrin-Based Protein Corona

Although traditionally regarded as an impediment, the protein corona can facilitate the advancement of targeted drug delivery systems. This study presents an innovative approach for targeting acute myeloid leukemia (AML) using nanoparticles with agglutinated protein (NAPs). Agglutinated transferrin and C3b in NAPs selectively bind to CD71 and CD11b, receptors that are overexpressed on myeloid leukemic cells compared to nonmalignant cells. <i>In vitro</i>, NAPs achieved a 73.9% doxorubicin (DOX) uptake in leukemic cells, compared to 6.19% for the free drug, while significantly reducing off-target accumulation in normal cells from 42.9% to 5.76%. <i>In vivo</i>, the distribution of NAPs correlated to the organ infiltration pattern of leukemic cells. NAPs demonstrated antileukemic activity in both <i>in vitro</i> and <i>in vivo</i> NSG mouse models, inducing cell death via apoptosis and ferroptosis. In conclusion, NAP-mediated targeted drug delivery represents a promising therapeutic strategy for AML, enhancing treatment efficacy and minimizing off-target effects.

Authors

Institutions

Publication Details

Journal
Nano Letters
Published
2024-12-18
DOI
https://doi.org/10.1021/acs.nanolett.4c04429
Citations
4
Primary Topic
Iron Metabolism and Disorders
Type
article
Field-Weighted Citation Impact
1.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dual-Targeted Drug Delivery to Myeloid Leukemia Cells via Complement- and Transferrin-Based Protein Corona

Guodong Sun, Hui Shao, Tao Liu, Wu Wen et al.
4 citations
Nano Letters
Iron Metabolism and Disorders
1.82
article

Dual-Targeted Drug Delivery to Myeloid Leukemia Cells via Complement- and Transferrin-Based Protein Corona

Guodong Sun, Hui Shao, Tao Liu, Wu Wen, Haiyan Liu, Yihan Wang, Fangfang Chen, Yanan Zhao, Ping Ren, Jiayi Feng, Qihui Liu, Ying Tang, Yuansong Bai, Yuan-Yuan Li
article en
4 citations

Abstract

Although traditionally regarded as an impediment, the protein corona can facilitate the advancement of targeted drug delivery systems. This study presents an innovative approach for targeting acute myeloid leukemia (AML) using nanoparticles with agglutinated protein (NAPs). Agglutinated transferrin and C3b in NAPs selectively bind to CD71 and CD11b, receptors that are overexpressed on myeloid leukemic cells compared to nonmalignant cells. <i>In vitro</i>, NAPs achieved a 73.9% doxorubicin (DOX) uptake in leukemic cells, compared to 6.19% for the free drug, while significantly reducing off-target accumulation in normal cells from 42.9% to 5.76%. <i>In vivo</i>, the distribution of NAPs correlated to the organ infiltration pattern of leukemic cells. NAPs demonstrated antileukemic activity in both <i>in vitro</i> and <i>in vivo</i> NSG mouse models, inducing cell death via apoptosis and ferroptosis. In conclusion, NAP-mediated targeted drug delivery represents a promising therapeutic strategy for AML, enhancing treatment efficacy and minimizing off-target effects.

Nano LettersVol. 25(1)
Union Hospital (HK), Jinan University (CN), Jilin University (CN), First Hospital of Jilin University (CN), Union Hospital (CN), State Key Laboratory of Inorganic Synthesis and Preparative Chemistry
Natural Science Foundation of Jilin Province, National Natural Science Foundation of China, Jilin University, National Key Research and Development Program of China, Program for Jilin University Science and Technology Innovative Research Team
Good health and well-being
Openalex Percentile: Top 13%
Iron Metabolism and Disorders
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.